PerkinElmer, Inc. (PKI) News

PerkinElmer, Inc. (PKI): $173.81

-2.74 (-1.55%)

POWR Rating

Component Grades













Filter PKI News Items

PKI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PKI News Highlights

  • For PKI, its 30 day story count is now at 71.
  • Over the past 26 days, the trend for PKI's stories per day has been choppy and unclear. It has oscillated between 1 and 19.
  • MN, SA and GENE are the most mentioned tickers in articles about PKI.

Latest PKI News From Around the Web

Below are the latest news stories about Perkinelmer Inc that investors may wish to consider to help them evaluate PKI as an investment opportunity.

Adult Hemoglobinopathy Testing Market See Huge Growth by 2028 | PerkinElmer, Inc., Streck, Inc., Thermo Fisher Scientific, Inc., Trinity Biotech PLC

Global Adult Hemoglobinopathy Testing Market is estimated to be worth USD 430 Million by 2028, expanding at a CAGR of +3% during 2021-2028. The Global analytical report titled Adult Hemoglobinopathy Testing Market has been recently published by Market Research Inc to

OpenPR | September 23, 2021

Biological Chip Market Evolve in Near Future | Abbott, Agilent Technologies, Illumina, PerkinElmer

The Biological Chip market research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study []

iCrowdNewswire | September 23, 2021

Global Mutational Analysis Market Technological Advancements & Competitive Insights To 2028|| Agilent Technologies Inc, GENERAL ELECTRIC COMPANY, PerkinElmer, Inc., QIAGEN, Eurofins Scientific, Quest Diagnostics Incorporated

Data Bridge Market Research analyses that the mutational analysis market will exhibit a CAGR of around 12.10% for the forecast period of 2021-2028. Overall growth in the genomics support in advance medicines, increased focus on research and development proficiencies in

OpenPR | September 22, 2021

PerkinElmer Completes Acquisition of BioLegend; Street Says Buy

PerkinElmer (PKI) announced that it has completed the acquisition of BioLegend, a global developer and manufacturer of antibodies and reagents. The cash and stock deal worth $5.25 billion was announced in July 2021. PerkinElmer provides solutions to diagnostics, life science, food and applied markets. With this deal, PerkinElmer will be able to expand its life science franchise, particularly in the areas like cytometry, proteogenomics, multiplex assays and bioprocessing. Earlier, PerkinElmer said that the acquisition might be accretive to its revenues and margin profile. Following the completion of the deal, about $0.30 of adjusted EPS accretion is expected in the first year and over $0.50 in the second year.

Radhika Saraogi on TipRanks | September 20, 2021

PerkinElmer (PKI) to Benefit From BioLegend Buyout: Here's How

PerkinElmer's (PKI) latest acquisition is likely to expand its life science business and enhance its reagents portfolio.

Yahoo | September 20, 2021

Mass. Covid-19 test makers poised to meet demand following Biden order

Local diagnostic makers like PerkinElmer Inc. and Eurofins Inc. have spent the last year and a half supplying Covid-19 tests to governments, school districts and businesses. But after President Biden's announcement, they're expecting more demand.

Yahoo | September 20, 2021

PerkinElmer Consensus Indicates Potential -3.3% Downside

PerkinElmer with ticker code (PKI) have now 13 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 199 and 160 calculating the mean target price we have 180.69. Given that the stocks previous close was at 186.84 this would imply there is a potential downside of -3.3%. There is a 50 day moving average of 184.66 and the 200 day moving average is 151.37. The company has a market capitalisation of $20,834m. Visit the company website at: /> [stock_market_widget type="chart" symbol="PKI" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] PerkinElmer provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytica...

DirectorsTalk | September 17, 2021

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents

Business Wire | September 17, 2021

Analysis on Impact of covid-19 Gas Chromatography Market 2020-2027 | Agilent Technologies, Shimadzu, Thermo Fisher Scientific, Perkinelmer, Merck Kgaa

Gas Chromatography Market forecast to 2027 The Global Gas Chromatography Market report provides information about the Global industry, including valuable facts and figures. This research study explores the Global Market in detail such as industry chain structures, raw material suppliers, with manufacturing The Gas Chromatography Sales market examines the primary segments of the scale of []

Cheshire Media | September 17, 2021

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Yahoo | September 17, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0613 seconds.